Research Antibodies & Reagents Market by Product (Antibodies, Reagent), Technology (Enzyme-linked Immunosorbent Assay, Flow Cytometry, Immunofluorescence), Indication, Application, End User - Global Forecast 2024-2030
The Research Antibodies & Reagents Market size was estimated at USD 16.54 billion in 2023 and expected to reach USD 18.55 billion in 2024, at a CAGR 12.02% to reach USD 36.62 billion by 2030.
Research antibodies are proteins produced by the body's immune system to respond to harmful substances or antigens, such as bacteria and viruses. Scientists synthetically produce these antibodies in laboratories for research purposes. Laboratory-produced research antibodies bind to specific antigens, thus marking them for identification, detection, or neutralization. These antibodies are integral in many research operations, including enzyme-linked immunosorbent assay (ELISA), immunohistochemistry, flow cytometry, western blotting, and immunofluorescence. Reagents in the context of scientific research refer to any substance that is utilized to induce a chemical reaction or to experiment if a reaction occurs. The wide array of research reagents entails enzymes, solvents, catalysts, buffers, and more, each with distinct uses and applications. Reagents play critical roles in molecular biology research, facilitating processes such as DNA replication, RNA transcription, protein synthesis, and cell lysis. The research antibodies and reagents market refers to the products, tools, and services researchers use in various fields such as healthcare, biotechnology, pharmaceuticals, and academic institutions to study diverse biological processes. Several factors contribute to the growth of the research antibodies and reagents market, including increasing research activities by pharmaceutical and biopharmaceutical companies and the rising popularity of proteomics and genomics research. The emerging trend of research antibodies & reagents in personalized medicine and protein therapeutics supports this upward market growth. However, the growth of the research antibodies and reagents market is facing certain challenges, including the high cost of antibody development processes, and quality concerns, and a lack of reproducible results of research antibodies & reagents. On the other hand, increasing R&D in research antibodies & reagents and rising focus on discovering novel biomarkers present potential opportunities for the market to grow in the coming years.
Regional Insights
Americas represents a highly developing landscape characterized by substantial investments in R&D activities by pharmaceutical and biotechnological companies and the presence of multiple research institutes. Additionally, the recent increase in patented scientific research augments the demand for research antibodies & reagents in the Americas. Significant governmental initiatives and investments to expand biotechnology research and development with advanced research equipment and tools are expected to foster the growth of the research antibodies & reagents market in Asia-Pacific. In May 2021, the Australian Government committed USD 206.4 million to a patent box tax incentive scheme to encourage investment in Australia's biotechnology and medical technology sectors. Asia's vast population, focus on investments in specialized clinical trial centers, and government support for clinical trials are significant factors in the region's reputation as a hub for successful clinical trials. The research antibodies & reagents market witnessed substantial growth in Europe, the Middle East, and African (EMEA) regions owing to the ongoing development of the life science industry. According to the United Kingdom Government, the country's healthy life science sector contributes more than USD 66 billion and 220,000 jobs annually to the UK economy.
Market Insights
- Market Dynamics
The market dynamics represent an ever-changing landscape of the Research Antibodies & Reagents Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.- Market Drivers
- Increasing research activities by pharmaceutical and biopharmaceutical companies
- Rising popularity of proteomics and genomics research
- Emerging trend of research antibodies & reagents in personalized medicine and protein therapeutics
- Market Restraints
- High cost of antibody development processes
- Market Opportunities
- Increasing R&D in research antibodies & reagents
- Rising focus on discovering novel biomarkers
- Market Challenges
- Quality concerns and a lack of reproducible results of research antibodies & reagents
- Market Segmentation Analysis
- Product: Increasing popularity of antibodies for detection and quantification of target proteins
- Technology: Increasing usage of research antibodies & reagents in flow cytometry for immunophenotyping
- Indication: Expanding application of research antibodies & reagents for identification of pathogens in infectious diseases
- Application: Rising utilization of research antibodies and reagents for drug development tailored to specific therapeutic targets
- End-user: Expanding usage of research antibodies & reagents across pharmaceutical & biotechnology companies
- Market Disruption Analysis
- Porter’s Five Forces Analysis
- Value Chain & Critical Path Analysis
- Pricing Analysis
- Technology Analysis
- Patent Analysis
- Trade Analysis
- Regulatory Framework Analysis
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Research Antibodies & Reagents Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Research Antibodies & Reagents Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments- GenScript Expands Range of Reagent Services, Adding Circular RNA and Lipid Nanoparticles Formulation
GenScript Biotech Corporation has expanded its IVT mRNA synthesis portfolio by offering customized circular RNA (circRNA) and lipid nanoparticles (LNPs) formulation services. GenScript's comprehensive turnkey solution ensures that scientists receive full scientific support, from sequence design to vial delivery.
Bio-Rad Laboratories, Inc. Extends Range of Antibody Markers Conjugated to StarBright Dyes
Bio-Rad Laboratories, Inc. has launched the 29th StarBright Dye, called StarBright Red 670. Additionally, they have expanded their current range by introducing 29 more antibodies conjugated to StarBright Blue 700 and StarBright Violet 610 Dyes. The newly added targets include human and mouse antibody markers and cow, dog, and pig targets for veterinary immunology research.
Danaher to Acquire Abcam plc
Danaher Corporation has acquired Abcam plc in a cash transaction valued at approximately USD 5.7 billion. This strategic move aims to leverage Abcam plc's expertise in mapping complex diseases and accelerate the drug discovery process. This acquisition marks a significant milestone in research antibodies and reagents, ensuring the continued availability of high-quality products and services to researchers worldwide.
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Research Antibodies & Reagents Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Research Antibodies & Reagents Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies Inc., Alpha Teknova, Inc., Atlas Antibodies AB, Avantor, Inc., BASF SE, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, bioMérieux S.A., Cardinal Health, Inc., Cell Signaling Technology, Inc., Charles River Laboratories International, Inc., Danaher Corporation, Dovetail Genomics LLC, Enzo Life Sciences, Inc., F. Hoffmann-La Roche Ltd., FUJIFILM Holdings Corporation, GenScript Biotech Corporation, Honeywell International Inc., Illumia, Inc., ImmunoPrecise Antibodies Ltd., Leinco Technologies, Inc., LifeSpan BioSciences, Inc., LobaChemie Pvt. Ltd., Lonza Group Ltd., Merck KGaA, Omega Bio-tek, Inc., PerkinElmer, Inc., QIAGEN N.V., Randox Laboratories Ltd., Rockland Immunochemicals, Inc., Santa Cruz Biotechnology, Inc., Sino Biological, Inc., Thermo Fisher Scientific, Inc., Tokyo Chemical Industry Co., Ltd., and Tosoh Corporation.
Market Segmentation & Coverage
This research report categorizes the Research Antibodies & Reagents Market to forecast the revenues and analyze trends in each of the following sub-markets:- Product
- Antibodies
- Monoclonal Antibodies
- Polyclonal Antibodies
- Recombinant Antibodies
- Reagent
- Buffers
- Enzymes
- Fixatives
- Media & Sera
- Probes
- Solvents
- Stains & Dyes
- Technology
- Enzyme-linked Immunosorbent Assay
- Flow Cytometry
- Immunofluorescence
- Immunohistochemistry
- Immunoprecipitation
- Western Blotting
- Indication
- Immunology
- Infectious Diseases
- Neurobiology
- Oncology
- Stem Cells
- Application
- Drug Development
- Genomics
- Proteomics
- End User
- Academic & Research Institutions
- Contract Research Organizations
- Pharmaceutical & Biotechnology
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
Please Note: PDF & Excel + Online Access - 1 Year
- Americas
- Antibodies
- Market Drivers
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing research activities by pharmaceutical and biopharmaceutical companies
- 5.1.1.2. Rising popularity of proteomics and genomics research
- 5.1.1.3. Emerging trend of research antibodies & reagents in personalized medicine and protein therapeutics
- 5.1.2. Restraints
- 5.1.2.1. High cost of antibody development processes
- 5.1.3. Opportunities
- 5.1.3.1. Increasing R&D in research antibodies & reagents
- 5.1.3.2. Rising focus on discovering novel biomarkers
- 5.1.4. Challenges
- 5.1.4.1. Quality concerns and a lack of reproducible results of research antibodies & reagents
- 5.2. Market Segmentation Analysis
- 5.2.1. Product: Increasing popularity of antibodies for detection and quantification of target proteins
- 5.2.2. Technology: Increasing usage of research antibodies & reagents in flow cytometry for immunophenotyping
- 5.2.3. Indication: Expanding application of research antibodies & reagents for identification of pathogens in infectious diseases
- 5.2.4. Application: Rising utilization of research antibodies and reagents for drug development tailored to specific therapeutic targets
- 5.2.5. End-user: Expanding usage of research antibodies & reagents across pharmaceutical & biotechnology companies
- 5.3. Market Trend Analysis
- 5.3.1. Increasing government investment for drug discovery coupled with robust foothold of major companies in Americas region
- 5.3.2. Improving healthcare infrastructure and rising investment in life sciences research in the Asia-Pacific region
- 5.3.3. Expanding government support for research and development in the field of genomics and strong foothold of major biotechnology companies in the EMEA region
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework Analysis
- 6. Research Antibodies & Reagents Market, by Product
- 6.1. Introduction
- 6.2. Antibodies
- 6.3. Reagent
- 7. Research Antibodies & Reagents Market, by Technology
- 7.1. Introduction
- 7.2. Enzyme-linked Immunosorbent Assay
- 7.3. Flow Cytometry
- 7.4. Immunofluorescence
- 7.5. Immunohistochemistry
- 7.6. Immunoprecipitation
- 7.7. Western Blotting
- 8. Research Antibodies & Reagents Market, by Indication
- 8.1. Introduction
- 8.2. Immunology
- 8.3. Infectious Diseases
- 8.4. Neurobiology
- 8.5. Oncology
- 8.6. Stem Cells
- 9. Research Antibodies & Reagents Market, by Application
- 9.1. Introduction
- 9.2. Drug Development
- 9.3. Genomics
- 9.4. Proteomics
- 10. Research Antibodies & Reagents Market, by End User
- 10.1. Introduction
- 10.2. Academic & Research Institutions
- 10.3. Contract Research Organizations
- 10.4. Pharmaceutical & Biotechnology
- 11. Americas Research Antibodies & Reagents Market
- 11.1. Introduction
- 11.2. Argentina
- 11.3. Brazil
- 11.4. Canada
- 11.5. Mexico
- 11.6. United States
- 12. Asia-Pacific Research Antibodies & Reagents Market
- 12.1. Introduction
- 12.2. Australia
- 12.3. China
- 12.4. India
- 12.5. Indonesia
- 12.6. Japan
- 12.7. Malaysia
- 12.8. Philippines
- 12.9. Singapore
- 12.10. South Korea
- 12.11. Taiwan
- 12.12. Thailand
- 12.13. Vietnam
- 13. Europe, Middle East & Africa Research Antibodies & Reagents Market
- 13.1. Introduction
- 13.2. Denmark
- 13.3. Egypt
- 13.4. Finland
- 13.5. France
- 13.6. Germany
- 13.7. Israel
- 13.8. Italy
- 13.9. Netherlands
- 13.10. Nigeria
- 13.11. Norway
- 13.12. Poland
- 13.13. Qatar
- 13.14. Russia
- 13.15. Saudi Arabia
- 13.16. South Africa
- 13.17. Spain
- 13.18. Sweden
- 13.19. Switzerland
- 13.20. Turkey
- 13.21. United Arab Emirates
- 13.22. United Kingdom
- 14. Competitive Landscape
- 14.1. Market Share Analysis, 2023
- 14.2. FPNV Positioning Matrix, 2023
- 14.3. Competitive Scenario Analysis
- 14.3.1. GenScript Expands Range of Reagent Services, Adding Circular RNA and Lipid Nanoparticles Formulation
- 14.3.2. Bio-Rad Laboratories, Inc. Extends Range of Antibody Markers Conjugated to StarBright Dyes
- 14.3.3. Danaher to Acquire Abcam plc
- 14.3.4. ERS Genomics & Santa Cruz Biotechnology Enter Into CRISPR/Cas9 Licensing Agreement
- 14.3.5. Teknova Announces Opening of New GMP-Certified Facility, Increasing Manufacturing Capacity for Custom, High-Quality Life Sciences Reagents
- 14.3.6. Lonza Group Ltd. to Acquire Synaffix and Strengthen Antibody-Drug Conjugates Offering
- 14.3.7. BD and A*STAR Collaborate to Advance Ultra-High Dimensional Analysis in Flow Cytometry for Immunology Research
- 14.3.8. Teknova and Sartorius Look to Address Critical Pain Points in AAV Bioprocessing
- 14.3.9. Bio-Techne And Cell Signaling Technology Announce Partnership To Validate Simple Western Antibodies
- 14.3.10. Cytek Biosciences, Inc. Partners with Bio-Rad Laboratories, Inc. to Expand Reagent Portfolios
- 15. Competitive Portfolio
- 15.1. Key Company Profiles
- 15.2. Key Product Portfolio
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook